Pan-cancer analysis of genomic scar signatures associated with homologous recombination deficiency suggests novel indications for existing cancer drugs
Andrea Marion Marquard(University of Copenhagen), Nicolai J. Birkbak(Brigham and Women's Hospital), Zhigang C. Wang(Dana-Farber Cancer Institute), Andrea L. Richardson(Johns Hopkins University), Zoltán Szállási(Semmelweis University), Daniel P. Silver(Dana-Farber Cancer Institute), Marcin Krzystanek(Technical University of Denmark), Aron C. Eklund(Dana-Farber Cancer Institute), Tejal Joshi(Technical University of Denmark), Francesco Favero(Technical University of Denmark)
Cited by 321
Related Papers
Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis
|Cell|2004|3.8k
Molecular Definition of Breast Tumor Heterogeneity
|Cancer Cell|2007|1.4k